Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × Caffeine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 cMET-dysregulated Advanced Solid Tumors 1 Pain 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Gastrointestinal Stromal Tumors 1 Fatigue 1 Diverticulitis 1 Confusion 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Anxiety Disorders 1

Interventions

Fluorouracil 407 Bevacizumab 382 Oxaliplatin 362 Leucovorin 355 Irinotecan 334 Cetuximab 264 Capecitabine 261 pembrolizumab 120 Folfox protocol 108 Panitumumab 93 regorafenib 89 Colonoscopy 72 IFL protocol 71 Drug Therapy 66 Nivolumab 64 trifluridine tipiracil drug combination 59 Radiotherapy 57 HMPL-013 51 Blood Specimen Collection 48 Neoadjuvant Therapy 42 Gemcitabine 41 Specimen Handling 39 Standard of Care 36 Chemotherapy, Adjuvant 36 Biopsy 36 Cyclophosphamide 35 Surveys and Questionnaires 33 Magnetic Resonance Spectroscopy 32 atezolizumab 31 Trifluridine 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02510911 2021-08-04

CaCo

Cantonal Hospital of St. Gallen

Phase NA Terminated

Gastrointestinal

Diverticulitis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡